Related Experiment Video
Updated: Jun 13, 2025

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Effect of remimazolam for general anesthesia on postoperative nausea and vomiting : A systematic review and
Su Yeon Kim1, Kyu Man Sim1, Hyo-Seok Na1,2
1Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, 82, Gumiro 173, 13620, Bundang, Seongnam, Gyeonggi, Korea (Republic of).
Background:
Benzodiazepines reduce postoperative nausea and vomiting (PONV); however, conflicting results have been reported regarding the use of remimazolam, a novel benzodiazepine.
Objective:
This meta-analysis examines whether remimazolam reduces PONV incidence compared with propofol or volatile agents used in general anesthesia.
Material And Methods:
Electronic databases, including PubMed, EMBASE, CENTRAL, and Web of Science, were searched on 31 July 2023. The primary outcome was the incidence of PONV. Secondary outcomes included PONV severity, rescue antiemetic use, amounts of remifentanil used, and participant satisfaction scores. Odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using a random-effects model. The risk of bias (RoB) was assessed using the Cochrane RoB2 tool.
Results:
A total of 1514 adult patients from 11 randomized controlled trials were included. The incidences of PONV in the remimazolam and control groups were 16.1% and 16.5%, respectively. Remimazolam did not increase the incidence of PONV (OR 0.62; 95% CI, 0.37-1.04; p = 0.0676; I2 = 48%). Subgroup analysis showed a significant reduction in PONV with remimazolam vs. volatile agents (OR 0.25; 95% CI, 0.13-0.47; P = 0.0000; I2 = 0%) but not vs. propofol (OR 1.04; 95% CI, 0.70-1.56; p = 0.8332; I2 = 0%). More remifentanil was used in the remimazolam group vs. the volatile group, with no significant difference between remimazolam and propofol groups. Participant satisfaction scores were higher with remimazolam.
Conclusion:
Remimazolam did not increase PONV risk compared to propofol and reduced PONV incidence compared to volatile agents, with higher participant satisfaction. To validate the present findings, further well-planned large clinical trials are required.
Insights
Remimazolam, a novel benzodiazepine, did not increase postoperative nausea and vomiting (PONV) risk compared to propofol. It significantly reduced PONV incidence versus volatile agents, enhancing patient satisfaction.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Benzodiazepines are used to mitigate postoperative nausea and vomiting (PONV).
- Conflicting evidence exists regarding the efficacy of remimazolam, a novel benzodiazepine, in preventing PONV.
Purpose of the Study:
- To evaluate if remimazolam reduces PONV incidence compared to propofol or volatile anesthetic agents.
- To assess secondary outcomes including PONV severity, antiemetic use, and patient satisfaction.
Main Methods:
- A meta-analysis of 11 randomized controlled trials involving 1514 adult patients.
- Systematic search of PubMed, EMBASE, CENTRAL, and Web of Science databases.
- Random-effects model used for calculating odds ratios and mean differences; Cochrane RoB2 tool for bias assessment.
Main Results:
- Remimazolam did not significantly alter overall PONV incidence (16.1% vs. 16.5%).
- Subgroup analysis revealed a significant PONV reduction with remimazolam versus volatile agents (OR 0.25), but not versus propofol (OR 1.04).
- Higher participant satisfaction scores were observed with remimazolam; remifentanil use varied between comparisons.
Conclusions:
- Remimazolam is a safe option regarding PONV risk compared to propofol.
- Remimazolam demonstrates efficacy in reducing PONV incidence when compared to volatile anesthetic agents.
- Higher patient satisfaction suggests potential benefits of remimazolam in clinical practice; further trials are warranted.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Related Concept Videos
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Parenteral Anesthetics: Overview
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Stages of General Anesthesia